Related Experiment Video

Updated: Jul 18, 2026

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Possible applications of antibodies or their genes in cancer therapy

Masahide Kuroki1, Jian Huang, Hirotomo Shibaguchi

  • 1Department of Biochemistry, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan. kurokima@fukuoka-u.ac.jp

Anticancer Research
|January 2, 2007
PubMed

Insights

This review explores anti-tumor-associated antigen (TAA) antibodies for cancer therapy. Applications include antibody-drug conjugates, enhanced immune responses, and targeted gene delivery, offering promising new treatment avenues.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Cancer immunotherapy is evolving with novel therapeutic strategies.
  • Tumor-associated antigens (TAAs) are key targets for cancer treatments.
  • Tumor escape mechanisms pose challenges to effective cancer therapies.

Purpose of the Study:

  • To summarize the diverse applications of anti-TAA antibodies in cancer therapy.
  • To highlight advancements in antibody-based cancer treatment modalities.
  • To discuss the potential of TAAs in overcoming tumor immune evasion.

Main Methods:

  • Review of current literature on anti-TAA antibody applications.
  • Analysis of therapeutic strategies involving monoclonal antibodies (MAbs).
  • Exploration of antibody conjugation, immune cell modulation, and gene therapy approaches.

Main Results:

  • Recombinant MAbs are increasingly used, often with anti-cancer drugs.
  • Antibody-toxin or radioisotope conjugates offer additional therapeutic options.
  • Enhancing cytotoxic T-lymphocyte (CTL) and natural killer (NK) cell activity against TAAs is crucial.
  • Targeting viral vectors using anti-TAA MAbs shows promise in cancer gene therapy.

Conclusions:

  • Anti-TAA antibodies represent a versatile platform for cancer therapy.
  • Combination therapies and immune cell modulation are vital for success.
  • Targeted delivery strategies, including gene therapy, offer new hope for cancer treatment.

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...